Asia Pacific Artificial Organs and Bionics Markets, Competition, Forecast & Opportunities, 2028 - ResearchAndMarkets.com

2023-01-27
DUBLIN--(BUSINESS WIRE)--The "Asia Pacific Artificial Organs and Bionics Market, By Products (Artificial heart, Artificial Kidneys, Bionic Limb, and Others), By Technology, By Material, By End-User, By Country, Competition, Forecast & Opportunities, 2028" report has been added to ResearchAndMarkets.com's offering.
'Organ donation in India - There is light at the end of the tunnel'
Asia Pacific artificial organs and bionics market is expected to grow at a significant rate during the forecast period, 2024-2028.
Rising cases of organ failures, along with scarcity of organ donors are anticipated to facilitate the growth of the market.
For instance, according to the article titled "Organ donation in India - There is light at the end of the tunnel" published in 2022, it is projected that every year, approximately 5 lakh Indians face organ failures, still less than 2%-3% of them receive a life-saving transplant.
Moreover, increasing cases of disabilities or road accidents which leads to amputations, are surging the demand for the replacement of the damaged part or organ, which, in turn, is bolstering the growth of the market.
The rising adoption of advanced technologies such as 3D bioprinting, artificial intelligence, and others are propelling the growth of the Asia-pacific artificial organs and bionics market.
However, compatibility issues between the organ donor and a transplant recipient are hampering the growth of the market. Besides, strict regulations associated with the artificial organs and bionics are expected to slow down the growth of the market.
Artificial kidneys held the dominant share in 2022, due to the increasing renal diseases, and failures, and growing elderly population. Based on country, Japan holds the maximum share of the market in the Asia Pacific region. This is attributed to the increase in the number of chronic diseases that lead to organ failure, rising older population, and increasing rate of road mishaps and resulting disabilities.
Collaboration and mergers with medical schools or research organizations is one of the key strategies of the companies to sustain and maintain their position in such highly competitive environment.
Objective of the Study:
To analyze and forecast the market size of Asia Pacific artificial organs and bionics market.
To classify and forecast Asia Pacific artificial organs and bionics market based on product, technology, material, end-user, company and country.
To identify drivers and challenges for Asia Pacific artificial organs and bionics market.
To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in Asia Pacific artificial organs and bionics market.
To conduct pricing analysis for Asia Pacific artificial organs and bionics market.
To identify and analyze the profile of leading players operating in Asia Pacific artificial organs and bionics market.
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in Asia Pacific artificial organs and bionics market.
ABIOMED.
Report Scope:
Asia Pacific Artificial Organs and Bionics Market, By Products:
Artificial Heart
Artificial Kidneys
Bionic Limb
Others
Asia Pacific Artificial Organs and Bionics Market, By Technology:
Suction Technology
Implanted myoelectric sensor (IMES) technology
Socket-Based Technology
3D Bioprinting
Others
Asia Pacific Artificial Organs and Bionics Market, By Material:
Plastics
Metal
Polymer
Asia Pacific Artificial Organs and Bionics Market, By End User:
Hospitals
Surgical Centers
Others
Asia Pacific Artificial Organs and Bionics Market, By Country:
China
India
Japan
South Korea
Singapore
Australia
Vietnam
Malaysia
Indonesia
Philippines
For more information about this report visit https://www.researchandmarkets.com/r/jttqjk-pacific?w=4
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
靶点
-
药物
-
来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。